Mercer Global Advisors
ANAB icon

Mercer Global Advisors’s AnaptysBio ANAB Stock Holding History

Mercer Global Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Buy
+1,727
New +$105K ﹤0.01% 3714

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Mercer Global Advisors's ANAB Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in AnaptysBio (ANAB) in Q2 2026: 1,727 shares worth $117K. The stake represents ﹤0.01% of the portfolio and ranks #3714 among its holdings.

191 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Mercer Global Advisors held 1,727 shares of AnaptysBio worth $117K as of Q2 2026.
  • AnaptysBio was a new Mercer Global Advisors position in Q2 2026.
  • AnaptysBio made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3714 holding.
  • 191 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.